Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MVCT Imaging Pilot Study Using Helical Tomotherapy

This study has been completed.
Cross Cancer Institute
Information provided by (Responsible Party):
AHS Cancer Control Alberta Identifier:
First received: September 9, 2005
Last updated: February 23, 2016
Last verified: December 2011
To compare the two types of scans, the conventional CT planning scan and the tomotherapy planing scan.

Cancer, Carcinoma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: MVCT Imaging Pilot Study Using Helical Tomotherapy

Resource links provided by NLM:

Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 16
Study Start Date: October 2003
Study Completion Date: August 2009
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinic

Inclusion Criteria:

  • Undergoing radiotherapy metallic artifact in radiation field.

Exclusion Criteria:

  • Contraindication to radiotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00168142

Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
AHS Cancer Control Alberta
Cross Cancer Institute
Principal Investigator: Rufus Scrimger, MD AHS Cancer Control Alberta
  More Information

Responsible Party: AHS Cancer Control Alberta Identifier: NCT00168142     History of Changes
Other Study ID Numbers: 21131 
Study First Received: September 9, 2005
Last Updated: February 23, 2016
Health Authority: Canada: Ethics Review Committee

Keywords provided by AHS Cancer Control Alberta:
Helical tomotherapy
Megavoltage imaging processed this record on October 21, 2016